Course of Gubra A/S' Annual General Meeting 2025

April 3, 2025 8:30 AM

Gubra (CPH:GUBRA)On Thursday, 3 April 2025 at 10:00 am (CEST), the annual general meeting of Gubra A/S (the "Company") was held at the Company's registered address Hørsholm Kongevej 11B, DK-2970 Hørsholm, with the following agenda:1. The board of directors' report on the Company's activities during the past financial year2. Presentation of the audited annual report for adoption3. Resolution on the appropriation of profit or payment of loss in...

Read more

CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company

April 3, 2025 8:00 AM

CASI Pharmaceuticals, Inc. (Nasdaq:CASI, "CASI"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that its special committee of the board of directors (the "Special Committee") has received an updated preliminary non-binding proposal letter (the "Proposal Letter"), dated April 2, 2025, from Dr. Wei-Wu He, Chairman of the board of directors...

Read more

Senzime Comments on US Market Tariffs

April 3, 2025 6:30 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime comments on the April 2 announcement on imposed new US import tariffs effective April 9, 2025."We have different options on the table to mitigate the effects of the tariffs. One is utilizing our new US headquarters in St Louis for local market production. We also have a strong local supply chain that is not imposed to tariffs by this US Presidential order. And obviously, we have already...

Read more

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

April 3, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be participating in an Analyst-Moderated fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9th, 2025, at 1:30 pm ET. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the...

Read more

DEA's Diversion Division - Patterns of MMJ's Marijuana Court Case Obstruction, Bias, and Corruption

April 3, 2025 5:00 AM

The U.S. Drug Enforcement Administration (DEA) is currently under intense scrutiny following allegations of systematic obstruction and corruption within its Diversion Control Division. Central figures in these allegations include Anne Milgram, past DEA Administrator, Thomas Prevoznik Deputy Administrator and Matthew Strait Policy Administrator, and other senior officials within the division, whose actions are now being questioned in light of...

Read more

Kementec Solutions Partners With Bioz to Enhance Researcher Experience Through Advanced Digital Integration

April 3, 2025 4:00 AM

Bioz, Inc., a pioneer in AI-powered publication management, is pleased to announce a strategic partnership with Kementec Solutions, a provider of high-quality sustainable solutions. This collaboration brings Bioz Badges and a Bioz Content Hub to Kementec's website, offering researchers an enhanced browsing experience with easy access to scientific content.Through this seamless integration, Kementec users can now view Bioz's AI-powered Prime...

Read more

AlzeCure Pharma publishes its Annual Report for 2024

April 3, 2025 2:20 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that its Annual Report for 2024 has been published."2024 was yet another active and successful year for AlzeCure Pharma. The year began with new preclinical data in our clinical Alzheimer's program showing that...

Read more

Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report

April 3, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has submitted its Annual Report to the U.S. Food and Drug Administration (FDA) under the active Investigational New Drug (IND) application for HG-CT-1, the Company's proprietary CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia (R/R AML).The annual report provides a comprehensive update on the Company's activities under the IND during the...

Read more

Gautam J. Desai, DO, FACOFP dist., Named 2025-2026 President of the American College of Osteopathic Family Physicians

April 2, 2025 7:00 PM

The American College of Osteopathic Family Physicians (ACOFP) announced that Gautam J. Desai, DO, FACOFP dist., has begun his one-year term as president after being installed in the office during the ACOFP's 62nd Annual Convention & Scientific Seminars in Palm Springs, California. He is the organization's first Indian American President."I am proud to accept the office of ACOFP president," said Dr. Desai. "Being president during our 75th...

Read more

American College of Osteopathic Family Physicians Announces 2025-2026 Board of Governors

April 2, 2025 7:00 PM

The American College of Osteopathic Family Physicians (ACOFP) announces its new Board of Governors, following their election on Wednesday, April 2, 2025, during the ACOFP Congress of Delegates in Palm Springs, California. New appointments include:President Gautam J. Desai, DO, FACOFP dist.President-Elect Greg D. Cohen, DO, FACOFP dist.Secretary/Treasurer David A. Connett, DO, FACOFP dist.Governor Jennifer L. Gwilym, DO, FACOFP dist.Resident...

Read more

My Compounding Pharmacy Roselands, Based in Sydney Australia Reviews Their Customized Anesthetic Solutions

April 2, 2025 6:45 PM

When it comes to personalized healthcare, compounding pharmacies are uniquely positioned to deliver tailored solutions for both human and veterinary needs. Among these innovative providers, My Compounding Pharmacy of Roselands stands out as a leader in crafting medications that address specific patient requirements. From adjusting dosages to omitting allergens and creating formulations that step outside conventional pharmaceutical boundaries,...

Read more

Duly Health and Care Partners with Fullscript to Recommend and Ship Premium Supplements Directly to Patients

April 2, 2025 2:00 PM

Duly Health and Care, through one of its med­ical groups, today launched an inno­v­a­tive new part­ner­ship with Fullscript, a lead­ing health­care plat­form for whole per­son care, to rec­om­mend and dis­trib­ute sup­ple­ments and vit­a­mins direct­ly to patients."Duly is com­mit­ted to empow­er­ing the patients we care for to take con­trol of their health," said Dr. Paul Mer­rick, Chief Physi­cian Exec­u­tive and Chair­man of Duly Health and...

Read more

Annual Report 2024

April 2, 2025 1:45 PM

GOTHENBURG, SE / ACCESS Newswire / April 2, 2025 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)Today XVIVO Perfusion AB (publ) publish the Annual Report for 2024. The Annual Report is attached to this press release in pdf format and in ESEF format and is also available on https://www.xvivogroup.com/investors/reports-and-presentations/.April 2, 2025Molndal, SwedenXVIVO Perfusion AB (publ)For further information, please contact:Christoffer...

Read more

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

April 2, 2025 1:20 PM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced that it has entered into definitive agreements in a registered direct offering with institutional investors for the purchase and sale of approximately $2.46 million of shares of Common Stock and pre-funded warrants at a price of $2.07...

Read more

SFWJ / Medcana Announces Successful Export of First CBD Crop

April 2, 2025 12:40 PM

Software Effective Solutions Corp. (OTC PINK:SFWJ), doing business as Medcana, is proud to announce the successful export of its first pharmaceutical-grade CBD crop through its Colombian partner, Anutea S.A.S., marking a significant operational milestone in the company's international expansion strategy.The crop, projected initially to yield 10 kilograms, exceeded expectations by delivering 18 kilograms of premium-quality CBD flower. The...

Read more

Owen Mumford Introduces Unifine(R)OTC Pen Needles: A Cash-Pay Solution for Pharmacies

April 2, 2025 12:00 PM

Owen Mumford is pleased to announce the launch of UnifineOTC, a new line of over-the-counter pen needles designed to help pharmacies better serve patients managing diabetes amid increasing out-of-pocket healthcare costs. With a low MSRP and trusted Unifine® quality, this offering creates a valuable opportunity for pharmacy teams to simplify operations while supporting patients facing coverage challenges.UnifineOTC eliminates the complexities of...

Read more

Exousia Pro Has Appointed Matthew Dwyer As Its New President

April 2, 2025 11:50 AM

MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is pleased to announce the appointment of Matthew Dwyer to serve as President of the Company.Mr. Dwyer will serve as President only and will not be a member of the Board. Mr. Dwyer brings over 37 years of market experience and is considered an expert in the OTC market. Mr. Dwyer possesses extensive...

Read more

Centre for Neuro Skills Named to Newsweek’s America's Greatest Midsize Workplaces 2025

April 2, 2025 11:30 AM

Newsweek named Centre for Neuro Skills (CNS), a leading provider of post-acute brain injury and stroke rehabilitation services, one of America's Greatest Midsize Workplaces for 2025. CNS is the only neurorehabilitation provider listed in the healthcare category, achieving a 5-star rating. "We are incredibly honored to receive this recognition from Newsweek," said David Harrington, president and CEO of CNS. "At Centre for Neuro Skills, we believe...

Read more

Black Book Finds Tariff Pressures Driving Reshoring of U.S. Healthcare Manufacturing

April 2, 2025 10:00 AM

A Q1 2025 ad hoc survey conducted by Black Book Research of 60 pharmaceutical and biotech manufacturing executives - half based in the U.S. and half operating offshore - reveals mounting momentum for reshoring U.S. healthcare manufacturing. The findings point to tariff-driven incentives, automation adoption, and supply chain vulnerabilities as central catalysts prompting a strategic shift in sourcing strategies across pharmaceuticals,...

Read more

PCs for People Partners with EdLogics and The Birdsong Health Literacy Center of Excellence to Launch 'Rewards for Healthy People' Platform

April 2, 2025 9:05 AM

PCs for People, a leading nonprofit dedicated to bridging the digital divide, is proud to announce a strategic partnership with EdLogics and the Birdsong Health Literacy Center of Excellence (BHLCOE). This partnership was formed with a goal of helping PCs for People improve the health literacy of its members by providing free access to Rewards for Healthy People, a customized version of EdLogics' innovative game-based health education platform....

Read more